DCF — BRYAN MEDICAL CENTER
Enterprise Value: $545.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$545.0M
Enterprise Value
$139.0M
PV of Cash Flows
$406.0M
PV of Terminal Value
$653.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $869.0M | $74.6M | 9.0% | $24.6M | $22.3M |
| Year 2 | $895.1M | $85.8M | 10.0% | $32.0M | $26.5M |
| Year 3 | $921.9M | $97.6M | 11.0% | $39.9M | $30.0M |
| Year 4 | $949.6M | $105.2M | 11.0% | $44.7M | $30.5M |
| Year 5 | $978.1M | $110.8M | 11.0% | $47.8M | $29.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $545.0M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$843.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08082526202754742
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5